SAN DIEGO, May 10, 2010 /PRNewswire via COMTEX/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, May 17, 2010, at 11:05 a.m. local time (6:05 a.m. Eastern time), in the Albemarle Suite at the Grosvenor House Hotel in London.
Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals Web site at www.adventrx.com. An archived presentation will be available on the Web site for 30 days.
About ADVENTRX Pharmaceuticals ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are designed to improve the performance of existing cancer treatments by addressing limitations associated principally with their safety and use. More information can be found on the Company's Web site at www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals, Inc.
www.prnewswire.com Copyright (C) 2010 PR Newswire. All rights reserved -0- KEYWORD: California
England INDUSTRY KEYWORD: HEA
BIO SUBJECT CODE: TDS